| Channa Hudson, MS | |
|
507 W Main St, Louisville, MS 39339-2559 | |
| (662) 773-9377 | |
| (662) 773-6025 |
| Full Name | Channa Hudson |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 507 W Main St, Louisville, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417424292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Channa Hudson, MS 302 N Jackson St, Starkville, MS 39759-2504 Ph: (662) 323-9318 | Channa Hudson, MS 507 W Main St, Louisville, MS 39339-2559 Ph: (662) 773-9377 |
News Archive
Semafore Pharmaceuticals today reported encouraging data from a Phase I dose-escalation trial of SF1126 in patients with relapsed and refractory myeloma. SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival. PI3K is commonly altered in human cancers, making inhibition of the target attractive for cancer therapy.
An interdisciplinary research team led by The University of Texas Medical Branch at Galveston reports a new breakthrough in countering the deadly effects of radiation exposure. A single injection of a regenerative peptide was shown to significantly increase survival in mice when given 24 hours after nuclear radiation exposure.
Every major medical center in America sits on a gold mine. The data they hold about their patients and research participants could be worth millions of dollars to companies that would explore it for clues that could lead to new medicines, medical technologies, health apps, and more.
Treatment with the insulin degludec compared to glargine U100 for 32 weeks resulted in a reduced rate of hypoglycemic (low blood sugar) episodes among patients with type 1 or 2 diabetes and at least one risk factor for hypoglycemia, according to two studies published by JAMA.
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds that a diet rich in soy prevents weight gain in post-menopausal female rats.
› Verified 4 days ago
Stephanie Taylor, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Yen Chu Chen, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Daphne Holmes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Ms. Michelle J Plante, LPC, CCAP, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Kimberly Letrese Carter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Marquita Smith, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 | |
Aleesha O Robinson, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 507 W Main St, Louisville, MS 39339 Phone: 662-773-9377 Fax: 662-773-9025 |